https://de.marketscreener.com/kurs/aktie/ARCELLX-INC-132884730/news/Arcellx-Inc-kundigt-mundliche-Prasentation-der-Phase-1-Studie-mit-CART-ddBCMA-bei-Patienten-mit-45225742/?utm_source=telegram&utm_medium=social&utm_campaign=share